Prescription drug · ANDA
Buprenorphine and Naloxone NDC 42858-602
Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 · Tablet · Sublingual · Rhodes Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42858-602-03 | 4285806020342858060203 | 30 TABLET in 1 BOTTLE, PLASTIC (42858-602-03)Marketed from Apr 13, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Buprenorphine and Naloxone
- Generic name (nonproprietary)
- buprenorphine and naloxone
- Active ingredients
- Buprenorphine hydrochloride — 8 mg/1Naloxone hydrochloride dihydrate — 2 mg/1
- Dosage form
- Tablet
- Route
- Sublingual
- Labeler
- Rhodes Pharmaceuticals LLCNDC labeler code 42858
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205601
- Marketing start
- Listing expires
- DEA schedule
- CIII
- Other FDA classes
- Opioid Antagonists (Mechanism)Partial Opioid Agonists (Mechanism)
- Identifiers
- Product ID 42858-602_57ae52a6-e7e9-442f-897f-e016078b4f11SPL ID 57ae52a6-e7e9-442f-897f-e016078b4f11SPL set ID 794724a6-0fba-bc8d-ecdb-9e3be8ea2191RxCUI 351266, 351267UNII 5Q187997EE, 56W8MW3EN1
- Pharmacologic class
- Opioid Antagonist; Partial Opioid Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Sublingual products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442858060203followed by a unit qualifier and the quantityPackage 42858-0602-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Buprenorphine and naloxone sublingual tablets are indicated for maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablets contain buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. ( 1 ) Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 42858-602
- What is NDC 42858-602?
- 42858-602 is the product NDC for Buprenorphine and Naloxone, Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 tablet, listed with the FDA by Rhodes Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Buprenorphine and Naloxone.
- What is the active ingredient?
- Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate.
- Who is the labeler?
- Rhodes Pharmaceuticals LLC, NDC labeler code 42858. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Buprenorphine and Naloxone?
- 50 other product NDCs are listed under this name. See all Buprenorphine and Naloxone NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Buprenorphine and Naloxone products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Buprenorphine And Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride 2 mg/1 | TabletSublingual | Ascend Laboratories, LLC | 67877-606 | 67877-0606-3067877-0606-8467877-0606-90 |
| Buprenorphine And Naloxone | Buprenorphine hydrochloride 2 mg/1; Naloxone hydrochloride .5 mg/1 | TabletSublingual | Ascend Laboratories, LLC | 67877-607 | 67877-0607-3067877-0607-8467877-0607-90 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 2 mg/1; Naloxone hydrochloride .5 mg/1 | Film, SolubleBuccal, Sublingual | Camber Pharmaceuticals, Inc. | 31722-479 | 31722-0479-30 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 4 mg/1; Naloxone hydrochloride 1 mg/1 | Film, SolubleBuccal, Sublingual | Camber Pharmaceuticals, Inc. | 31722-480 | 31722-0480-30 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride 2 mg/1 | Film, SolubleBuccal, Sublingual | Camber Pharmaceuticals, Inc. | 31722-481 | 31722-0481-30 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 12 mg/1; Naloxone hydrochloride 3 mg/1 | Film, SolubleBuccal, Sublingual | Camber Pharmaceuticals, Inc. | 31722-482 | 31722-0482-30 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 | TabletSublingual | Unit Dose Solutions, Inc. | 87441-001 | 87441-0001-01 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 2 mg/1; Naloxone hydrochloride dihydrate .5 mg/1 | TabletSublingual | Camber Pharmaceuticals, Inc. | 31722-850 | 31722-0850-30 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 | TabletSublingual | Camber Pharmaceuticals, Inc. | 31722-851 | 31722-0851-30 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 2 mg/1; Naloxone hydrochloride .5 mg/1 | FilmBuccal, Sublingual | Aveva Drug Delivery Systems Inc. | 3215-6521 | 03215-6521-30 |
Other NDCs under ANDA 205601
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 | TabletSublingual | Bryant Ranch Prepack | 71335-2981 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 2 mg/1; Naloxone hydrochloride dihydrate .5 mg/1 | TabletSublingual | Bryant Ranch Prepack | 63629-9482 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 | TabletSublingual | Bryant Ranch Prepack | 63629-9483 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 | TabletSublingual | Unit Dose Solutions, Inc. | 87441-001 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 | TabletSublingual | Bryant Ranch Prepack | 71335-2828 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 | TabletSublingual | Redpharm Drug | 67296-2164 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 2 mg/1; Naloxone hydrochloride dihydrate .5 mg/1 | TabletSublingual | Bryant Ranch Prepack | 72162-1346 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 | TabletSublingual | Bryant Ranch Prepack | 72162-1347 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 2 mg/1; Naloxone hydrochloride dihydrate .5 mg/1 | TabletSublingual | American Health Packaging | 60687-626 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 | TabletSublingual | American Health Packaging | 60687-637 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride dihydrate 2 mg/1 | TabletSublingual | REMEDYREPACK INC. | 70518-3389 |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 2 mg/1; Naloxone hydrochloride dihydrate .5 mg/1 | TabletSublingual | Rhodes Pharmaceuticals LLC | 42858-601 |